Gross margin was 85.8% for the third quarter of 2025 compared to 84.1% in the third quarter of 2024. The year-over-year increase was due to higher sales volume and higher Inspire V sales mix, which ...

Wondering whether Inspire Medical Systems is trading at a bargain or if there's more behind its current price? Let's dig deeper together and separate hype from real value. The stock has seen a sharp ...

At this time, I would like to welcome everyone to the Inspire Medical Systems Third Quarter 2025 Conference Call. [Operator Instructions] I'll now hand the call over to your first speaker, Ezgi Yagci, ...

The Russell 2500 Index was up 9.00%. The Wasatch Long/Short Alpha Fund—Investor Class did not keep pace and finished the ...

Inspire Medical Systems, which produces an implant to treat sleep apnea, extended the run spots involving the Golden Bachelorette winner through the holidays.

Research led by Korea University Ansan Hospital reports finding an association between moderate to severe obstructive sleep ...

Mayo Clinic researchers have developed an artificial intelligence (AI) algorithm that can identify obstructive sleep apnea (OSA) using the results from an electrocardiogram (ECG)—a common heart test.

Rochester, Minn.-based Mayo Clinic has developed an AI algorithm that can detect obstructive sleep apnea using electrocardiogram results.

A new Brain Medicine review maps how gut microbes influence sleep disorders, from insomnia and sleep apnea to circadian ...

Medical technology company Inspire Medical Systems (NYSE:INSP) in Q3 CY2025, with sales up 10.5% year on year to $224.5 ...